| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Division of Medical Oncology, Department of Medicine, Columbia University, New York, New York 10032 [J. E. G., R. N. T., S. F., S. K., M. R.]; Winthrop University Hospital, Division of Oncology/Hematology, Mineola, New York 11501 [A. A. H.]; and Toronto General Hospital, Toronto, Ontario, Canada M5G 1L7 [M. A. B.]
Four well defined multidrug-resistant cell lines and their drug-sensitive counterparts were examined for intracellular distribution of daunorubicin (DNR) by laser-assisted confocal fluorescence microscopy: P-glycoprotein-negative HL-60/AR cells, and P-glycoprotein-positive P388/ADR, KBV-1, and MCF-7/ADR cells.
Both drug sensitive cell lines (HL-60/S, P388/S, KB3-1, and MCF-7/S) and drug-resistant cell lines (HL-60/AR, P388/ADR, KBV-1, and MCF-7/ADR) exposed to DNR showed a similar rapid distribution of drug from the plasma membrane to the perinuclear region within the first 2 min. From 210 min, the drug sensitive HL-60/S, P388/S, and MCF-7/S cells redistributed drug to the nucleus and to the cytoplasm in a diffuse pattern. In contrast, drug-resistant HL-60/AR, P388/ADR, and MCF-7/ADR redistributed DNR from the perinuclear region into vesicles distinct from nuclear structures, thereby assuming a "punctate" pattern. This latter redistribution could be inhibited by glucose deprivation (indicating energy dependence), or by lowering the temperature of the medium below 18°C. The differences in distribution between sensitive and resistant cells did not appear to be a function of intracellular DNR content, nor the result of drug cytotoxicity.
Drug-sensitive KB3-1 and -resistant KBV-1 cells did not fully follow this pattern in that they demonstrated an intracellular DNR distribution intermediate between HL-60/S and HL-60/AR cells with both "punctate" and nuclear/cytoplasmic uptake sometimes in the same cell. These data indicate that the intracellular distribution of DNR is an important determinant of drug resistance regardless of the overexpression of P-glycoprotein. The intracellular movement of drug requires the presence of glucose and a temperature above 18°C, implicating energy-dependent processes and vesicle fusion in the distribution process. This intracellular transport of DNR away from the nucleus in multidrug-resistant cells may protect putative cell targets such as DNA against drug toxicity.
1 Supported by Grants ACS CH-357, CA-31761, CA-42450, and CA-40188, and the William J. Matheson Foundation, the Medical Research Council of Canada, and the National Cancer Institute of Canada.
2 To whom requests for reprints should be addressed, at Columbia University Cancer Center, 630 168th Street, VC 12-213, New York, NY 10032.
Received 9/21/90. Accepted 7/ 9/91.
This article has been cited by other articles:
![]() |
A. van Zon, M. H. Mossink, M. Schoester, R. J. Scheper, P. Sonneveld, and E. A. C. Wiemer Efflux Kinetics and Intracellular Distribution of Daunorubicin Are Not Affected by Major Vault Protein/Lung Resistance-Related Protein (Vault) Expression Cancer Res., July 15, 2004; 64(14): 4887 - 4892. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-K. Li, P. J. Houghton, S. D. Desai, P. Daroui, A. A. Liu, E. S. Hars, A. L. Ruchelman, E. J. LaVoie, and L. F. Liu Characterization of ARC-111 as a Novel Topoisomerase I-Targeting Anticancer Drug Cancer Res., December 1, 2003; 63(23): 8400 - 8407. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lansiaux, F. Tanious, Z. Mishal, L. Dassonneville, A. Kumar, C. E. Stephens, Q. Hu, W. D. Wilson, D. W. Boykin, and C. Bailly Distribution of Furamidine Analogues in Tumor Cells: Targeting of the Nucleus or Mitochondria Depending on the Amidine Substitution Cancer Res., December 15, 2002; 62(24): 7219 - 7229. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. B. Lichtner, A. Rotgeri, T. Bunte, B. Buchmann, J. Hoffmann, W. Schwede, W. Skuballa, and U. Klar Subcellular distribution of epothilones in human tumor cells PNAS, September 13, 2001; (2001) 171023398. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Cabrita, T. C. Hobman, D. L. Hogue, K. M. King, and C. E. Cass Mouse Transporter Protein, a Membrane Protein That Regulates Cellular Multidrug Resistance, Is Localized to Lysosomes Cancer Res., October 1, 1999; 59(19): 4890 - 4897. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Altan, Y. Chen, M. Schindler, and S. M. Simon Defective Acidification in Human Breast Tumor Cells and Implications for Chemotherapy J. Exp. Med., May 18, 1998; 187(10): 1583 - 1598. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Millot, J.-M. Millot, H. Morjani, A. Desplaces, and M. Manfait Characterization of Acidic Vesicles in Multidrug-resistant and Sensitive Cancer Cells by Acridine Orange Staining and Confocal Microspectrofluorometry J. Histochem. Cytochem., September 1, 1997; 45(9): 1255 - 1264. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Hurwitz, M. Terashima, N. Mizunuma, and C. A. Slapak Vesicular Anthracycline Accumulation in Doxorubicin-Selected U-937 Cells: Participation of Lysosomes Blood, May 15, 1997; 89(10): 3745 - 3754. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Cole, G Bhardwaj, J. Gerlach, J. Mackie, C. Grant, K. Almquist, A. Stewart, E. Kurz, A. Duncan, and R. Deeley Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line Science, December 4, 1992; 258(5088): 1650 - 1654. [Abstract] [PDF] |
||||
![]() |
R. B. Lichtner, A. Rotgeri, T. Bunte, B. Buchmann, J. Hoffmann, W. Schwede, W. Skuballa, and U. Klar Subcellular distribution of epothilones in human tumor cells PNAS, September 25, 2001; 98(20): 11743 - 11748. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |